These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 20345879)

  • 1. Analysis of serious non-AIDS events among HIV-infected adults at Latin American sites.
    Belloso WH; Orellana LC; Grinsztejn B; Madero JS; La Rosa A; Veloso VG; Sanchez J; Ismerio Moreira R; Crabtree-Ramirez B; Garcia Messina O; Lasala MB; Peinado J; Losso MH
    HIV Med; 2010 Oct; 11(9):554-64. PubMed ID: 20345879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of non-AIDS-defining events among HIV-infected patients not yet on antiretroviral therapy.
    Zhang S; van Sighem A; Kesselring A; Gras L; Prins JM; Hassink E; Kauffmann R; Richter C; de Wolf F; Reiss P;
    HIV Med; 2015 May; 16(5):265-72. PubMed ID: 25604160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of cancers during interrupted antiretroviral therapy in the SMART study.
    Silverberg MJ; Neuhaus J; Bower M; Gey D; Hatzakis A; Henry K; Hidalgo J; Lourtau L; Neaton JD; Tambussi G; Abrams DI
    AIDS; 2007 Sep; 21(14):1957-63. PubMed ID: 17721103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Natural history of human immunodeficiency virus infection in a cohort of Chilean patients].
    Vial PA; Ferreccio C; Abarca K; Ortiz E; Noriega M; Pérez C; Labarca J; Torres M; Ferrés M; González C; Acuña G
    Rev Med Chil; 1996 May; 124(5):525-35. PubMed ID: 9035503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AIDS-defining opportunistic illnesses in US patients, 1994-2007: a cohort study.
    Buchacz K; Baker RK; Palella FJ; Chmiel JS; Lichtenstein KA; Novak RM; Wood KC; Brooks JT;
    AIDS; 2010 Jun; 24(10):1549-59. PubMed ID: 20502317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The rate of serious bacterial infections among HIV-infected children with immune reconstitution who have discontinued opportunistic infection prophylaxis.
    Nachman S; Gona P; Dankner W; Weinberg A; Yogev R; Gershon A; Rathore M; Read JS; Huang S; Elgie C; Hudgens K; Hughes W
    Pediatrics; 2005 Apr; 115(4):e488-94. PubMed ID: 15772172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human immunodeficiency virus in an aging population, a complication of success.
    Kirk JB; Goetz MB
    J Am Geriatr Soc; 2009 Nov; 57(11):2129-38. PubMed ID: 19793157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AIDS-defining and non-AIDS-defining malignancies: cancer occurrence in the antiretroviral therapy era.
    Silverberg MJ; Abrams DI
    Curr Opin Oncol; 2007 Sep; 19(5):446-51. PubMed ID: 17762569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in AIDS-defining and non-AIDS-defining malignancies among HIV-infected patients: 1989-2002.
    Bedimo R; Chen RY; Accortt NA; Raper JL; Linn C; Allison JJ; Dubay J; Saag MS; Hoesley CJ
    Clin Infect Dis; 2004 Nov; 39(9):1380-4. PubMed ID: 15494916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and risk factors for the occurrence of non-AIDS-defining cancers among human immunodeficiency virus-infected individuals.
    Burgi A; Brodine S; Wegner S; Milazzo M; Wallace MR; Spooner K; Blazes DL; Agan BK; Armstrong A; Fraser S; Crum NF
    Cancer; 2005 Oct; 104(7):1505-11. PubMed ID: 16104038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune restoration and onset of new AIDS-defining events with combination antiretroviral therapy in HIV type-1-infected immigrants in the Netherlands.
    Kesselring AM; Gras L; Wit FW; Smit C; Geerlings SE; Mulder JW; Schreij G; Sprenger HG; Reiss P; de Wolf F
    Antivir Ther; 2010; 15(6):871-9. PubMed ID: 20834099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Setting a minimum threshold CD4 count for initiation of highly active antiretroviral therapy in HIV-infected patients.
    Ho C; Lee S; Wong Kh; Cheng L; Lam M
    HIV Med; 2007 Apr; 8(3):181-5. PubMed ID: 17461862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AIDS-associated cancers: an emerging challenge.
    Phatak UA; Joshi R; Badakh DK; Gosavi VS; Phatak JU; Jagdale RV
    J Assoc Physicians India; 2010 Mar; 58():159-62. PubMed ID: 20848813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between current level of immunodeficiency and non-acquired immunodeficiency syndrome-defining malignancies.
    Reekie J; Kosa C; Engsig F; Monforte Ad; Wiercinska-Drapalo A; Domingo P; Antunes F; Clumeck N; Kirk O; Lundgren JD; Mocroft A;
    Cancer; 2010 Nov; 116(22):5306-15. PubMed ID: 20661911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interruption of combination antiretroviral therapy and risk of clinical disease progression to AIDS or death.
    Holkmann Olsen C; Mocroft A; Kirk O; Vella S; Blaxhult A; Clumeck N; Fisher M; Katlama C; Phillips AN; Lundgren JD;
    HIV Med; 2007 Mar; 8(2):96-104. PubMed ID: 17352766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interruption of antiretroviral treatment in HIV-infected patients with preserved immune function is associated with a low rate of clinical progression: a prospective study by AIDS Clinical Trials Group 5170.
    Skiest DJ; Su Z; Havlir DV; Robertson KR; Coombs RW; Cain P; Peterson T; Krambrink A; Jahed N; McMahon D; Margolis DM;
    J Infect Dis; 2007 May; 195(10):1426-36. PubMed ID: 17436222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of clinical progression in antiretroviral-naive HIV-infected patients starting highly active antiretroviral therapy. Aquitaine Cohort, France, 1996-2002.
    Bonnet F; Thiébaut R; Chêne G; Neau D; Pellegrin JL; Mercié P; Beylot J; Dabis F; Salamon R; Morlat P;
    HIV Med; 2005 May; 6(3):198-205. PubMed ID: 15876287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of PI and NNRTI HAART-based therapy on oral lesions of Brazilian HIV-infected patients.
    Ortega KL; Vale DA; Magalhães MH
    J Oral Pathol Med; 2009 Jul; 38(6):489-94. PubMed ID: 19453845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of CD4+ T lymphocytes at diagnosis of acquired immunodeficiency syndrome-defining and other human immunodeficiency virus-related illnesses. The Adult and Adolescent Spectrum of HIV Disease Project Group.
    Hanson DL; Chu SY; Farizo KM; Ward JW
    Arch Intern Med; 1995 Jul; 155(14):1537-42. PubMed ID: 7605156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.
    Clifford GM; Polesel J; Rickenbach M; Dal Maso L; Keiser O; Kofler A; Rapiti E; Levi F; Jundt G; Fisch T; Bordoni A; De Weck D; Franceschi S;
    J Natl Cancer Inst; 2005 Mar; 97(6):425-32. PubMed ID: 15770006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.